We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Blood Iron Test Predicts Fatal Outcomes

By LabMedica International staff writers
Posted on 14 Apr 2014
Print article
Image: The Coulter Electronic Counter (Photo courtesy of Beckman Coulter).
Image: The Coulter Electronic Counter (Photo courtesy of Beckman Coulter).
The transferrin saturation (TSAT) ratio is a commonly used indicator of iron deficiency and iron overload in clinical practice, but precise relationships with total and cardiovascular mortality are equivocal.

The test is a measure of the amount of available iron in the bloodstream with low levels generally reflecting a state of iron deficiency and high levels suggesting a relative excess which can be detrimental to health.

Scientists at the University of Limerick (Ireland) studied 15,823 participants, 20 years of age or older, who had a valid serum creatinine value. Serum creatinine values were used to determine the estimated glomerular filtration rate (eGFR) in mL/min/1.73 m2 for all participants. Blood samples were obtained from nonfasting persons and frozen serum sent for analysis.

Serum iron and total iron binding capacity were measured colorimetrically (Alpkem RFA analyzer; Clackamas, OR, USA), and serum ferritin was measured with the Quantimmune IRMA kit (Bio-Rad Laboratories; Hercules, CA, USA). Hemoglobin was measured using a Coulter S-Plus Jr electronic counter (Coulter Electronics; Hialeah, FL, USA). Serum creatinine concentrations were measured by the modified kinetic Jaffe reaction using a Hitachi 737 analyzer (Boehringer Mannheim Corp.; Indianapolis, IN, USA).

The study found that subjects with extremely low transferrin saturation levels of less that 17.5% were at a 45% higher risk of death. On the other hand, the risk of death was also significantly higher for subjects with very high levels of transferrin saturation above 31.3 %. The mean values for TSAT were 26.3 %; hemoglobin 14.2 g/dL and serum ferritin level 129 ng/mL. The association of TSAT with mortality differed by race and sex. Among whites and blacks, low and high TSAT levels were associated with higher mortality risk while no association was manifest in Mexican-Americans. For men, the impact on mortality was demonstrated only in older males, while for women the j-shaped mortality association was confined to younger females. High levels usually occur in states of iron overload like hemochromatosis, multiple blood transfusions and cirrhosis.

Austin G. Stack MD MSc, a professor and senior author of the study said, “Our analysis suggests that the optimal transferrin saturation range for patient survival should be between 23% to 40% and that careful clinical assessment is warranted for patients with low and high levels in order to identify states of iron deficiency or iron excess. Our study demonstrates that transferrin saturation ratio is a useful prognostic tool in assessing a patient's health and while we support the correction of low transferrin saturation levels in the general population, we would also advise caution against excessive iron loading to levels beyond 40%.” The study was published on March 5, 2014, in the Quarterly Journal of Medicine.

Related Links:

University of Limerick
Alpkem
Bio-Rad


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.